Navigating Therapy Options and Targeted Medications in Metastatic Non-Small Cell Lung Cancer

Exploring the significance of targeted medications over traditional treatments, focusing on mutations like EGFR, ALC, and ROS1. The chapter delves into specific treatments such as Osimertinib for EGFR mutations, resistance patterns, and the complexities of treating EGFRX on 20 mutations.